Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Longitudinal Analysis of Heparin-Binding Protein (HBP) and Serum Amyloid a Protein (SAA) Versus Interleukin 6 (IL-6), C-Reactive Protein (CRP), and Procalcitonin (PCT) During Both the Acute Postoperative Period and Recovery at Three Months From Non-emergent Cardiac Surgery.

Clinical Medicine Insights. Cardiology·2026

Same author

Infective Endocarditis Masquerade: Aortic Prosthetic Valve Degeneration and Mitral Prosthetic Valve Thrombosis Mimicking Infective Endocarditis.

JACC. Case reports·2026

Same author

Reoperations after the Ross procedure: Techniques, complexity, and outcomes.

JTCVS structural and endovascular·2026

Same author

A snare technique for valve-in-valve transcatheter aortic valve replacement in a stented coarctation of the aorta: a case report.

Frontiers in cardiovascular medicine·2026

Same author

Transcatheter Aortic Valve Replacement in Aortic Regurgitation Secondary to Aortic Valvulitis.

JACC. Case reports·2026

Same author

Quadruple-valve replacement in patients with carcinoid heart disease: A 24-year experience.

JTCVS open·2026

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Mechanical circulatory support for the visually impaired: is it appropriate?

Yazhini Ravi¹, Michael Firstenberg, Juan Crestanello

¹The Ohio State University Medical Center, N816 North Doan Hall, 410 W 10th Avenue, Columbus, OH 43210, USA.

Expert Review of Medical Devices

|March 9, 2011

Summary

Current left ventricular assist device technology excludes visually impaired patients. This study reports on two patients who received mechanical circulatory support, overcoming visual impairment barriers.

More Related Videos

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

Area of Science:

Cardiology
Biomedical Engineering
Assistive Technology

Background:

Left ventricular assist devices (LVADs) are crucial for end-stage heart failure management.
Current LVAD controller and alarm systems are not designed for visually impaired patients.
This limits treatment options for a specific patient population.

Observation:

Two patients with decreased visual acuity were evaluated for long-term mechanical circulatory support.
Visual impairment was a key consideration in determining their eligibility.
The study highlights the challenges faced by visually impaired individuals seeking LVAD implantation.

Findings:

The study successfully managed two patients with visual impairment using long-term mechanical circulatory support.
It demonstrates that visual impairment does not necessarily preclude LVAD implantation.
Adaptations or considerations for the controller and alarm systems may be necessary.

Implications:

This work suggests a need for developing more inclusive LVAD technology.
It opens possibilities for visually impaired patients to benefit from advanced heart failure therapies.
Further research into accessible LVAD interfaces is warranted.